Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:25PM ET
17.50
Dollar change
-0.23
Percentage change
-1.30
%
IndexRUT P/E- EPS (ttm)-3.70 Insider Own39.06% Shs Outstand42.90M Perf Week7.10%
Market Cap753.73M Forward P/E- EPS next Y-3.43 Insider Trans-0.80% Shs Float26.25M Perf Month-3.21%
Income-153.16M PEG- EPS next Q-0.93 Inst Own64.04% Short Float3.56% Perf Quarter74.13%
Sales0.00M P/S- EPS this Y1.20% Inst Trans-1.51% Short Ratio2.23 Perf Half Y72.58%
Book/sh10.58 P/B1.65 EPS next Y5.96% ROA-29.28% Short Interest0.94M Perf Year66.98%
Cash/sh10.84 P/C1.61 EPS next 5Y- ROE-30.98% 52W Range7.64 - 19.68 Perf YTD71.74%
Dividend Est.- P/FCF- EPS past 5Y-62.42% ROI-33.60% 52W High-11.08% Beta0.33
Dividend TTM- Quick Ratio17.07 Sales past 5Y-25.00% Gross Margin- 52W Low129.06% ATR (14)0.83
Dividend Ex-Date- Current Ratio17.07 EPS Y/Y TTM-248.40% Oper. Margin0.00% RSI (14)56.96 Volatility3.81% 5.34%
Employees85 Debt/Eq0.01 Sales Y/Y TTM-100.00% Profit Margin- Recom1.00 Target Price25.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q4.99% Payout0.00% Rel Volume0.61 Prev Close17.73
Sales Surprise- EPS Surprise43.83% Sales Q/Q- EarningsMar 14 BMO Avg Volume419.57K Price17.50
SMA203.60% SMA506.72% SMA20051.60% Trades Volume159,506 Change-1.30%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wedbush Outperform $30
Jun-15-23Initiated TD Cowen Outperform
Nov-21-22Initiated BTIG Research Buy $20
Apr-27-21Upgrade Morgan Stanley Equal-Weight → Overweight $40
Feb-02-21Initiated SVB Leerink Outperform $52
Feb-02-21Initiated Morgan Stanley Equal-Weight $38
Feb-02-21Initiated Evercore ISI Outperform $55
Feb-01-21Initiated H.C. Wainwright Buy $47
Mar-16-24 05:31AM
Mar-14-24 12:53PM
07:00AM
Mar-01-24 07:00AM
Feb-27-24 08:00AM
09:21AM Loading…
Feb-21-24 09:21AM
Feb-02-24 11:01PM
Jan-30-24 11:01PM
Jan-24-24 07:02PM
Dec-18-23 04:53PM
Dec-14-23 04:30PM
Nov-08-23 07:00AM
Nov-03-23 12:01PM
Oct-30-23 08:00AM
Sep-06-23 08:00AM
07:00AM Loading…
Aug-10-23 07:00AM
Aug-09-23 07:00AM
Aug-03-23 04:15PM
Jul-31-23 08:00AM
Jun-09-23 04:07PM
May-25-23 05:00PM
May-11-23 04:01PM
Apr-26-23 10:08AM
Apr-20-23 07:00AM
Mar-29-23 10:13AM
Mar-27-23 07:00AM
Mar-14-23 04:35PM
Mar-09-23 07:00AM
Feb-27-23 08:00AM
Feb-13-23 07:00PM
04:01PM Loading…
Feb-02-23 04:01PM
Feb-01-23 04:42PM
Jan-24-23 08:00AM
Jan-23-23 11:07AM
Jan-03-23 05:13PM
Dec-28-22 10:31PM
Dec-02-22 05:00PM
Nov-14-22 07:00AM
Nov-02-22 08:00AM
Nov-01-22 05:23PM
07:00AM
Oct-25-22 07:00AM
Oct-03-22 04:50PM
Sep-07-22 08:00AM
Sep-01-22 05:27PM
Aug-15-22 04:57PM
Aug-10-22 07:00AM
Aug-01-22 04:55PM
08:00AM
Jul-29-22 05:00AM
05:00AM
Jul-05-22 04:01PM
Jul-01-22 04:37PM
Jun-23-22 08:00AM
Jun-01-22 05:00PM
May-31-22 08:00AM
May-26-22 08:45AM
May-19-22 08:00AM
May-16-22 06:45AM
May-12-22 11:18AM
02:00AM
May-08-22 09:23AM
May-02-22 05:00PM
Apr-27-22 10:00AM
Apr-05-22 08:00AM
Apr-04-22 04:34PM
Mar-29-22 07:54AM
Mar-28-22 04:01PM
Mar-17-22 07:08AM
07:00AM
Mar-09-22 08:00AM
Mar-08-22 05:30PM
Feb-28-22 08:00AM
Feb-12-22 06:50AM
Feb-07-22 06:30AM
Jan-10-22 06:30AM
Jan-05-22 09:00AM
Jan-04-22 07:34AM
07:00AM
Dec-16-21 01:04PM
06:30AM
Dec-13-21 07:00AM
Nov-22-21 12:37PM
Nov-14-21 07:04AM
Nov-09-21 06:45AM
Oct-29-21 11:47AM
Oct-18-21 07:00AM
Sep-08-21 04:01PM
Aug-16-21 06:44AM
Aug-10-21 06:30AM
Aug-05-21 04:05PM
Jul-19-21 07:56PM
Jun-29-21 08:00AM
Jun-07-21 10:57AM
09:26AM
08:30AM
Jun-04-21 11:53AM
09:00AM
May-21-21 08:00AM
May-19-21 05:00PM
Cullinan Oncology, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Savill CorrineChief Business OfficerFeb 01 '24Option Exercise4.3040,000172,000205,990Feb 02 09:35 PM
Savill CorrineChief Business OfficerFeb 01 '24Sale16.1840,000647,200165,990Feb 02 09:35 PM
Savill CorrineChief Business OfficerJan 29 '24Option Exercise4.3040,000172,000205,990Jan 30 07:00 PM
Savill CorrineChief Business OfficerJan 29 '24Sale14.0940,000563,600165,990Jan 30 07:00 PM
Savill CorrineChief Business OfficerJan 23 '24Option Exercise4.3021,31691,659187,306Jan 24 05:00 PM
Savill CorrineChief Business OfficerJan 23 '24Sale12.4621,316265,597165,990Jan 24 05:00 PM
Savill CorrineChief Business OfficerJan 22 '24Option Exercise4.3014,55962,604184,674Jan 24 05:00 PM
Savill CorrineChief Business OfficerJan 22 '24Sale12.1418,684226,911165,990Jan 24 05:00 PM
AHMED NADIMPresident and CEODec 26 '23Sale9.244,27239,473111,550Dec 27 06:30 PM
Trigilio JeffreyChief Financial OfficerDec 21 '23Sale8.501,92016,32083,919Dec 22 05:30 PM
Jones Jeffrey AlanChief Medical OfficerDec 21 '23Sale8.501,86015,81056,191Dec 22 05:30 PM
SUMER JACQUELYN LChief Legal OfficerDec 21 '23Sale8.501,40011,90044,133Dec 22 05:30 PM
Michaelson JenniferChief Scientific OfficerDec 21 '23Sale8.501,1459,73287,582Dec 22 05:30 PM
Trigilio JeffreyChief Financial OfficerDec 18 '23Sale8.223983,27285,839Dec 20 06:00 PM
Jones Jeffrey AlanChief Medical OfficerDec 18 '23Sale8.223863,17358,051Dec 20 06:00 PM
SUMER JACQUELYN LChief Legal OfficerDec 18 '23Sale8.222902,38445,533Dec 20 06:00 PM
Michaelson JenniferChief Scientific OfficerDec 18 '23Sale8.222381,95688,727Dec 20 06:00 PM
Trigilio JeffreyChief Financial OfficerDec 12 '23Sale7.811,92615,04286,237Dec 13 08:00 PM
Michaelson JenniferChief Scientific OfficerDec 12 '23Sale7.811,0688,34188,965Dec 13 08:00 PM
AHMED NADIMPresident and CEOJun 28 '23Sale11.407598,653115,822Jun 29 04:59 PM
Trigilio JeffreyChief Financial OfficerJun 20 '23Sale12.943995,16385,823Jun 21 04:17 PM
Jones Jeffrey AlanChief Medical OfficerJun 20 '23Sale12.943875,00858,437Jun 21 04:17 PM
SUMER JACQUELYN LChief Legal OfficerJun 20 '23Sale12.942913,76645,823Jun 21 04:17 PM
Michaelson JenniferChief Development OfficerJun 20 '23Sale12.942383,08090,033Jun 21 04:17 PM
Trigilio JeffreyChief Financial OfficerJun 12 '23Sale13.113194,18286,222Jun 14 04:35 PM
Michaelson JenniferChief Development OfficerJun 12 '23Sale13.111762,30790,271Jun 14 04:35 PM
Michaelson JenniferChief Development OfficerJun 07 '23Option Exercise4.3010043090,547Jun 08 05:10 PM
Michaelson JenniferChief Development OfficerJun 07 '23Sale12.401001,24090,447Jun 08 05:10 PM
Michaelson JenniferChief Development OfficerJun 06 '23Option Exercise4.3011,90051,170102,347Jun 08 05:10 PM
Michaelson JenniferChief Development OfficerJun 06 '23Sale12.3111,900146,48990,447Jun 08 05:10 PM
AHMED NADIMPresident and CEOMay 23 '23Sale9.157076,469116,581May 24 04:36 PM
Trigilio JeffreyChief Financial OfficerMay 18 '23Sale8.763993,49586,541May 19 04:44 PM
Jones Jeffrey AlanChief Medical OfficerMay 18 '23Sale8.763943,45158,824May 19 04:46 PM
SUMER JACQUELYN LChief Legal OfficerMay 18 '23Sale8.762912,54946,114May 19 04:45 PM
Michaelson JenniferChief Development OfficerMay 18 '23Sale8.762392,09490,447May 19 04:51 PM
Trigilio JeffreyChief Financial OfficerMay 12 '23Sale8.783473,04786,940May 16 05:28 PM
Michaelson JenniferChief Development OfficerMay 12 '23Sale8.781931,69590,686May 16 05:36 PM
AHMED NADIMPresident and CEOApr 25 '23Sale10.597167,582117,288Apr 26 04:23 PM
Trigilio JeffreyChief Financial OfficerApr 18 '23Sale10.713984,26387,287Apr 20 04:34 PM
Jones Jeffrey AlanChief Medical OfficerApr 18 '23Sale10.713924,19859,218Apr 20 04:38 PM
SUMER JACQUELYN LChief Legal OfficerApr 18 '23Sale10.712903,10646,405Apr 20 04:30 PM
Michaelson JenniferChief Development OfficerApr 18 '23Sale10.712382,54990,879Apr 20 04:32 PM
Trigilio JeffreyChief Financial OfficerApr 12 '23Sale10.223183,25087,685Apr 14 06:35 PM
Michaelson JenniferChief Development OfficerApr 12 '23Sale10.221761,79991,117Apr 14 06:23 PM